IBDEI3C1.m

IBDEI3C1 ; ; 04-FEB-2020

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.4,2523,0)

 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^193

 ;;^UTILITY(U,$J,358.4,2524,0)

 ;;=ACSC CHF^6^193

 ;;^UTILITY(U,$J,358.4,2525,0)

 ;;=ACSC DEHYDRATION^7^193

 ;;^UTILITY(U,$J,358.4,2526,0)

 ;;=ACSC DIABETES TYPE 1^8^193

 ;;^UTILITY(U,$J,358.4,2527,0)

 ;;=ACSC DIABETES TYPE 2^9^193

 ;;^UTILITY(U,$J,358.4,2528,0)

 ;;=ACSC HYPERTENSION^10^193

 ;;^UTILITY(U,$J,358.4,2529,0)

 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^193

 ;;^UTILITY(U,$J,358.4,2530,0)

 ;;=ACSC PNEUMONIA^12^193

 ;;^UTILITY(U,$J,358.4,2531,0)

 ;;=ACSC UTI^13^193

 ;;^UTILITY(U,$J,358.4,2532,0)

 ;;=ACSC VIRAL ENTERITIS^14^193

 ;;^UTILITY(U,$J,358.4,2533,0)

 ;;=E-CIG/VAPE LUNG INJURY^23^193

 ;;^UTILITY(U,$J,358.4,2534,0)

 ;;=ACSC ACUTE KIDNEY FAILURE^1^194

 ;;^UTILITY(U,$J,358.4,2535,0)

 ;;=ACSC ANGINA^2^194

 ;;^UTILITY(U,$J,358.4,2536,0)

 ;;=ACSC ASTHMA/BRONCHITIS/COPD^3^194

 ;;^UTILITY(U,$J,358.4,2537,0)

 ;;=ACSC CHF^4^194

 ;;^UTILITY(U,$J,358.4,2538,0)

 ;;=ACSC DEHYDRATION^5^194

 ;;^UTILITY(U,$J,358.4,2539,0)

 ;;=ACSC DIABETES TYPE 1^6^194

 ;;^UTILITY(U,$J,358.4,2540,0)

 ;;=ACSC DIABETES TYPE 2^7^194

 ;;^UTILITY(U,$J,358.4,2541,0)

 ;;=ACSC HYPERTENSION^8^194

 ;;^UTILITY(U,$J,358.4,2542,0)

 ;;=ACSC INFECTIOUS GASTROENTERITIS^9^194

 ;;^UTILITY(U,$J,358.4,2543,0)

 ;;=ACSC PNEUMONIA^10^194

 ;;^UTILITY(U,$J,358.4,2544,0)

 ;;=ACSC UTI^11^194

 ;;^UTILITY(U,$J,358.4,2545,0)

 ;;=ACSC VIRAL ENTERITIS^12^194

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---IBDEI3C1   1697     printed  Apr 09, 2024@20:58:32                                                                                                                                                                                                    Page 2

IBDEI3C1  ; ; 04-FEB-2020

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 +2        if 'DIFQR(358.4)

               QUIT 

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT 

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT 

 +1       ;;^UTILITY(U,$J,358.4,2523,0)

 +2       ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^193

 +3       ;;^UTILITY(U,$J,358.4,2524,0)

 +4       ;;=ACSC CHF^6^193

 +5       ;;^UTILITY(U,$J,358.4,2525,0)

 +6       ;;=ACSC DEHYDRATION^7^193

 +7       ;;^UTILITY(U,$J,358.4,2526,0)

 +8       ;;=ACSC DIABETES TYPE 1^8^193

 +9       ;;^UTILITY(U,$J,358.4,2527,0)

 +10      ;;=ACSC DIABETES TYPE 2^9^193

 +11      ;;^UTILITY(U,$J,358.4,2528,0)

 +12      ;;=ACSC HYPERTENSION^10^193

 +13      ;;^UTILITY(U,$J,358.4,2529,0)

 +14      ;;=ACSC INFECTIOUS GASTROENTERITIS^11^193

 +15      ;;^UTILITY(U,$J,358.4,2530,0)

 +16      ;;=ACSC PNEUMONIA^12^193

 +17      ;;^UTILITY(U,$J,358.4,2531,0)

 +18      ;;=ACSC UTI^13^193

 +19      ;;^UTILITY(U,$J,358.4,2532,0)

 +20      ;;=ACSC VIRAL ENTERITIS^14^193

 +21      ;;^UTILITY(U,$J,358.4,2533,0)

 +22      ;;=E-CIG/VAPE LUNG INJURY^23^193

 +23      ;;^UTILITY(U,$J,358.4,2534,0)

 +24      ;;=ACSC ACUTE KIDNEY FAILURE^1^194

 +25      ;;^UTILITY(U,$J,358.4,2535,0)

 +26      ;;=ACSC ANGINA^2^194

 +27      ;;^UTILITY(U,$J,358.4,2536,0)

 +28      ;;=ACSC ASTHMA/BRONCHITIS/COPD^3^194

 +29      ;;^UTILITY(U,$J,358.4,2537,0)

 +30      ;;=ACSC CHF^4^194

 +31      ;;^UTILITY(U,$J,358.4,2538,0)

 +32      ;;=ACSC DEHYDRATION^5^194

 +33      ;;^UTILITY(U,$J,358.4,2539,0)

 +34      ;;=ACSC DIABETES TYPE 1^6^194

 +35      ;;^UTILITY(U,$J,358.4,2540,0)

 +36      ;;=ACSC DIABETES TYPE 2^7^194

 +37      ;;^UTILITY(U,$J,358.4,2541,0)

 +38      ;;=ACSC HYPERTENSION^8^194

 +39      ;;^UTILITY(U,$J,358.4,2542,0)

 +40      ;;=ACSC INFECTIOUS GASTROENTERITIS^9^194

 +41      ;;^UTILITY(U,$J,358.4,2543,0)

 +42      ;;=ACSC PNEUMONIA^10^194

 +43      ;;^UTILITY(U,$J,358.4,2544,0)

 +44      ;;=ACSC UTI^11^194

 +45      ;;^UTILITY(U,$J,358.4,2545,0)

 +46      ;;=ACSC VIRAL ENTERITIS^12^194